Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-24 @ 11:52 PM
NCT ID:
NCT00322751
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically proven non-small cell lung cancer Stage I to IIIA.
* Inoperable lung cancer because of poor respiratory lung function, or other medical reasons, as determined by the thoracic surgeon.
* PS \< 2
* Age \> 18 years
* Life expectancy of \> 12 weeks
* Normal hematologic, liver, and renal function
* No metastatic disease as determined by CT-PET scanning and bone scan.
* No brain metastasis by MRI
* No contraindication to radiotherapy
Exclusion Criteria:
* Patients with uncontrolled CNS metastases.
* Active systemic infection.
* Serious, uncontrolled intercurrent medical or psychiatric illness.
* Secondary active primary malignancy.
* Inability to comply with requirements of the study.
* Any metastases outside of the mediastinum
* Histologically positive pleural or pericardial effusion
* Any chemotherapy within five years prior to enrollment on this protocol
* Prior radiotherapy administered to the chest
* Women who are pregnant or lactating
* FEV1 \< 1 liter/minute
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00322751
Study Brief:
Protocol Section:
NCT00322751